Fulminant Hemorrhagic Bullae of the Upper Extremities Arising in the Setting of IV Placement During Severe COVID-19 Infection: Observations From a Major Consultative PracticeAugust 4, 2021Infectious DiseasesWoundsCOVID-19 Updates
Dermatology NewsDelta variant could drive herd immunity threshold over 80%August 4, 2021COVID-19 UpdatesInfectious Diseases
Untreatable, drug-resistant fungus found in Texas and Washington, D.C.August 4, 2021Infectious Diseases
Dermatology NewsFDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 yearsAugust 2, 2021Autoimmune Diseases
Dermatology NewsFDA’s fast-track approval process exposed as lax, in need of reformJuly 30, 2021Mixed TopicsBusiness of Medicine
Dermatology NewsCOVID-19 leaves wake of medical debt among U.S. adultsJuly 30, 2021Business of MedicineDiversity in MedicinePractice Management
Dermatology NewsStudy highlights impact of acne in adult women on quality of life, mental healthJuly 30, 2021AcneMixed Topics
JAK inhibitors could be a promising alternative treatment option for atopic dermatitisJuly 29, 2021Atopic Dermatitis
Serum biomarker-based patient clusters identify heterogeneity in pediatric atopic dermatitisJuly 29, 2021Atopic Dermatitis
Higher maternal serum 25(OH)D levels may increase risk for early-onset infant atopic dermatitisJuly 29, 2021Atopic Dermatitis
Dupilumab is an effective treatment for atopic dermatitis, regardless of prior NSISS useJuly 29, 2021Atopic Dermatitis
